[Overexpression of SEMA3A may favor malignant activities of tumor cells/clinicopathol correlations suggest that SEMA3A might represent a novel intervention target for pancreatic cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE